ValitaCell is a biotechnology company that creates and commercialises analytical products and technologies for the biopharmaceutical industry. Our products enable clients bring innovative medicines to the market faster, cheaper and with greater regulatory confidence. ValitaCell's vision is to become a pioneer in biological science and cell therapy and to harness the power of artificial intelligence for both applications. ValitaCell is now part of the Beckman Coulter Life Sciences company.